Showing results (511-520 of 2,509) with videos related to
Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|September 17, 2025
Efficacy and Safety of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Multicenter Real-World ExperienceAnas Zayad, Gray Magee, Razan Mansour, et al.Clinical Lymphoma, Myeloma & Leukemia|September 12, 2025
Predicators and Outcomes of Cytomegalovirus Reactivation in Chimeric Antigen Receptor T-Cell Therapy: A Systematic ReviewMuhammad Atif Khan, Faiza Humayun Khan, Abat Khan, et al.Clinical Lymphoma, Myeloma & Leukemia|September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World CohortRachel E Christensen, Robert Stuver, Stephen Dusza, et al.Clinical Lymphoma, Myeloma & Leukemia|August 1, 2025
Rising Unmet Need in Multiple Myeloma Management After First-Line Treatment With DRd: Expected Epidemiological Evolution in ItalyMario Boccadoro, Riccardo Mercati, Chiara Vassallo, et al.Clinical Lymphoma, Myeloma & Leukemia|August 16, 2021
Resolution of One-Year Persisting COVID-19 Pneumonia and Development of Immune Thrombocytopenia in a Follicular Lymphoma Patient With Preceding Rituximab Maintenance Therapy: A follow-up Report and Literature Review of Cases With Prolonged InfectionsHajime Yasuda, Yosuke Mori, Asako Chiba, et al.Clinical Lymphoma, Myeloma & Leukemia|August 14, 2021
Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution ExperienceSanaz Ghafouri, Kathleen Fenerty, Gary Schiller, et al.Clinical Lymphoma, Myeloma & Leukemia|August 14, 2021
SOHO State of the Art Updates and Next Questions: The Past, Present and Future of Venetoclax-Based Therapies in AMLAnagha Inguva, Daniel A PollyeaClinical Lymphoma, Myeloma & Leukemia|August 18, 2021
Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple MyelomaAjai Chari, Erika Florendo, Ines Stefania Mancia, et al.Clinical Lymphoma, Myeloma & Leukemia|August 8, 2021
The Real-Life Efficacy of Fixed-Dose Hypomethylating Agents in Older Patients With Acute Myeloid Leukemia: A 10-Year ExperienceTarinee Rungjirajittranon, Smith Kungwankiattichai, Chutima Kunacheewa, et al.Clinical Lymphoma, Myeloma & Leukemia|August 10, 2021
Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic LeukemiaAbdul Hamid Bazarbachi, Myriam Labopin, Nicolaus Kröger, et al.Pageof 251